Williams syndrome is an epigenome-regulator disease

14Citations
Citations of this article
39Readers
Mendeley users who have this article in their library.

Abstract

A human multi-protein complex (WINAC), composed of SWI/SNF components and DNA replication-related factors, that directly interacts with the vitamin D receptor (VDR) through the Williams syndrome transcription factor (WSTF), was identiied with an ATP-dependent chromatin remodeling activity. This novel ATP-dependent chromatin remodeling complex facilitates VDR-mediated transrepression as well as transactivation with its ATP-dependent chromatin remodeling activity and promoter targeting property for the activator to access to the DNA. It also suggested that in this complex, WSTF serves as a signaling sensor to receive intra-cellular singalings to switch the activity of WINAC as well as WICH, another ATP-dependent chromatin remodeling complex containing hSNF2h. By making WSTF-deicient mice, some of the heart defects as well as abnormal calcium metabolism observed in Williams syndrome are attributed to the abnormal chromatin remodeling activity caused by WSTF deiciency. Thus, we would propose to designate Williams syndrome as an epigenome-regulator disease. © The Japan Endocrine Society.

Cite

CITATION STYLE

APA

Kitagawa, H., Fujiki, R., Yoshimura, K., Oya, H., & Kato, S. (2011). Williams syndrome is an epigenome-regulator disease. Endocrine Journal. https://doi.org/10.1507/endocrj.K10E-393

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free